Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease (Q27687627)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease |
scientific article |
Statements
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease (English)
Roland W Bürli
Christopher A Luckhurst
Omar Aziz
Kim L Matthews
Dawn Yates
Kathy A Lyons
Maria Beconi
George McAllister
Perla Breccia
Andrew J Stott
Stephen D Penrose
Michael Wall
Marieke Lamers
Ilka Müller
Christine M Richardson
Rebecca Jarvis
Liz Stones
Samantha Hughes
Grant Wishart
Alan F Haughan
Catherine O'Connell
Tania Mead
Hannah McNeil
Julie Vann
John Mangette
Michel Maillard
Ignacio Munoz-Sanjuan
Identifiers
2 references
2 references